0001193125-22-040700.txt : 20220214 0001193125-22-040700.hdr.sgml : 20220214 20220214122701 ACCESSION NUMBER: 0001193125-22-040700 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 GROUP MEMBERS: COLUMBIA MANAGEMENT INVESTMENT ADVISERS, LLC GROUP MEMBERS: COLUMBIA WANGER ASSET MANAGEMENT, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-45573 FILM NUMBER: 22628071 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: AMERIPRISE FINANCIAL INC CENTRAL INDEX KEY: 0000820027 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] IRS NUMBER: 133180631 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1099 AMERIPRISE FINANCIAL CENTER CITY: MINNEAPOLIS STATE: MN ZIP: 55474 BUSINESS PHONE: 612-671-8001 MAIL ADDRESS: STREET 1: 1099 AMERIPRISE FINANCIAL CENTER CITY: MINNEAPOLIS STATE: MN ZIP: 55474 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN EXPRESS FINANCIAL CORP DATE OF NAME CHANGE: 20030513 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN EXPRESS FINANCIAL ADVISORS DATE OF NAME CHANGE: 19950711 FORMER COMPANY: FORMER CONFORMED NAME: IDS FINANCIAL CORP/MN/ DATE OF NAME CHANGE: 19920703 SC 13G/A 1 d305500dsc13ga.htm SC 13G/A SC 13G/A

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Amendment #1

Under the Securities and Exchange Act of 1934

 

 

Anika Therapeutics Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

035255108

(CUSIP Number)

December 31, 2021

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

This Schedule is filed pursuant to Rule 13d-1(b)

The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

 

 

CUSIP NO. 035255108

 

  1)    

  Name of Reporting Person

 

  Ameriprise Financial, Inc.

 

  S.S. or I.R.S. Identification No. of Above Person

 

  IRS No. 13-3180631

  2)  

  Check the Appropriate Box if a Member of a Group

 

  (a)  ☐        (b)  ☒*

 

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Delaware

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

    5)    

  Sole Voting Power

 

  0

   6)  

  Shared Voting Power

 

  950,856

   7)  

  Sole Dispositive Power

 

  0

   8)  

  Shared Dispositive Power

 

  987,733

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  987,733

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  6.84%

12)  

  Type of Reporting Person

 

  HC

 

*

This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

CUSIP NO. 035255108

 

  1)    

  Name of Reporting Person

 

  Columbia Management Investment Advisers, LLC

 

  S.S. or I.R.S. Identification No. of Above Person

 

  IRS No. 41-1533211

  2)  

  Check the Appropriate Box if a Member of a Group

 

  (a)  ☐        (b)  ☒*

 

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Minnesota

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

    5)    

  Sole Voting Power

 

  0

   6)  

  Shared Voting Power

 

  950,771

   7)  

  Sole Dispositive Power

 

  0

   8)  

  Shared Dispositive Power

 

  987,361

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  987,361

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  6.84%

12)  

  Type of Reporting Person

 

  IA

 

*

This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

CUSIP NO. 73739W104

 

  1)    

  Name of Reporting Person

 

  Columbia Wanger Asset Management, LLC

 

  S.S. or I.R.S. Identification No. of Above Person

 

  IIRS No. 04-3519872

  2)  

  Check the Appropriate Box if a Member of a Group

 

  (a)  ☐        (b)  ☒*

 

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Delaware

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

    5)    

  Sole Voting Power

 

  0

   6)  

  Shared Voting Power

 

  766,289

   7)  

  Sole Dispositive Power

 

  0

   8)  

  Shared Dispositive Power

 

  766,289

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  766,289

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  5.31%

12)  

  Type of Reporting Person

 

  IA

 

*

This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

1(a)   Name of Issuer:   Anika Therapeutics Inc
1(b)   Address of Issuer’s Principal Executive Offices:   32 Wiggins Avenue
Bedford, MA 01730
2(a)   Name of Person Filing:   (a) Ameriprise Financial, Inc. (“AFI”)
    (b) Columbia Management Investment Advisers, LLC (“CMIA”)
    (c) Columbia Wanger Asset Management, LLC (“CWAM”)
2(b)   Address of Principal Business Office:   (a) Ameriprise Financial, Inc.
145 Ameriprise Financial Center
Minneapolis, MN 55474
    (b) 290 Congress St.
Boston, MA 02210
    (c) 71 S Wacker Dr., Suite 2500
Chicago, IL 60606
2(c)   Citizenship:   (a) Delaware
    (b) Minnesota
    (c) Delaware
2(d)   Title of Class of Securities:   Class A Common Stock
2(e)   Cusip Number:   035255108

 

3

Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b):

(a) Ameriprise Financial, Inc.

A parent holding company in accordance with Rule 13d-1(b)(1)(ii)(G). (Note: See Item 7)

(b) Columbia Management Investment Advisers, LLC

An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).

(c) Columbia Wanger Asset Management, LLC

An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).

 

4

Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person.

 

AFI, as the parent company of CMIA and CWAM, may be deemed to beneficially own the shares reported herein by those reporting persons. Accordingly, the shares reported herein by AFI include those shares separately reported herein by those reporting persons.

Each of AFI, CMIA and CWAM disclaims beneficial ownership of any shares reported on this Schedule.

 

5

Ownership of 5% or Less of a Class: Not Applicable

 

6

Ownership of more than 5% on Behalf of Another Person: Not Applicable

 

7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:

AFI: See Exhibit I

 

8

Identification and Classification of Members of the Group:

Not Applicable

 

9

Notice of Dissolution of Group:

Not Applicable

 

10

Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2022

 

Ameriprise Financial, Inc.
By:  

/s/ Michael G. Clarke

Name:   Michael G. Clarke
Title:   Senior Vice President, Head of Global Operations
Columbia Management Investment Advisers, LLC
By:  

/s/ Michael G. Clarke

Name:   Michael G. Clarke
Title:   Senior Vice President, Head of Global Operations
Columbia Wanger Asset Management, LLC
By:  

/s/ Joseph C. LaPalm

Name:   Joseph C. LaPalm
Title:   Chief Compliance Officer
Contact Information
Mark D. Braley
Vice President
Head of Reporting and Data Management| Global Operations and Investor Services
Telephone: (617) 747-0663

Exhibit Index

 

Exhibit I    Identification and Classification of the Subsidiary which acquired the Security Being Reported on by the Parent Holding Company.
Exhibit II    Joint Filing Agreement
 EX-99.I 2 d305500dex99i.htm EX-99.I EX-99.I

Exhibit I

to

Schedule 13G

Ameriprise Financial, Inc., a Delaware Corporation, is a parent holding company. The classification and identity of the relevant subsidiaries is as follows:

Investment Adviser – Columbia Management Investment Advisers, LLC is an investment adviser registered under section 203 of the Investment Advisers Act of 1940.

Investment Adviser – Columbia Wanger Asset Management, LLC is an investment adviser registered under section 203 of the Investment Advisers Act of 1940.

 

 EX-99.II 3 d305500dex99ii.htm EX-99.II EX-99.II

Exhibit II

to

Schedule 13G

Joint Filing Agreement

The undersigned persons agree and consent to the joint filing on their behalf of this Schedule 13G dated February 14, 2022, in connection with their beneficial ownership of Anika Therapeutics Inc. Each of, Columbia Wanger Asset Management, LLC and Columbia Management Investment Advisers, LLC authorizes Ameriprise Financial, Inc. to execute the Schedule 13G to which this Exhibit is attached and make any necessary amendments thereto.

 

Ameriprise Financial, Inc.
By:  

/s/ Michael G. Clarke

Name:   Michael G. Clarke
Title:   Senior Vice President, Head of Global Operations
Columbia Management Investment Advisers, LLC
By:  

/s/ Michael G. Clarke

Name:   Michael G. Clarke
Title:   Senior Vice President, Head of Global Operations
Columbia Wanger Asset Management, LLC
By:  

/s/ Joseph C. LaPalm

Name:   Joseph C. LaPalm
Title:   Chief Compliance Officer